Rapt Therapeutics Inc. buy me8
Start price
20.02.24
/
0%
€6.70
Target price
20.02.25
€10.00
Performance (%)
32.09%
End price
21.02.24
€8.85
Summary
This prediction ended on 21.02.24 with a price of €8.85. The BUY prediction by me8 for Rapt Therapeutics Inc. saw massive gains of 32.09%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rapt Therapeutics Inc. | -8.280% | -8.280% |
| iShares Core DAX® | 1.280% | 1.027% |
| iShares Nasdaq 100 | -2.457% | -4.650% |
| iShares Nikkei 225® | -2.006% | -2.091% |
| iShares S&P 500 | -0.662% | -1.246% |
According to me8 what are the pros and cons of Rapt Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Cons
Few uniques
Comments by me8 for this prediction
In the thread Rapt Therapeutics Inc. diskutieren
Buy Rapt Therapeutics Inc.
Kursziel gesetzt auf 10,0